Precision Medicine: Data & Stats in Drug Development
The Predictive Biomarker Revolution: From Oncology to Proactive Healthcare Over $10 billion is projected to be invested in the oncology biomarker market by 2028, but the true potential of predictive biomarkers extends far beyond cancer. We’re entering an era where proactive, personalized healthcare, guided by sophisticated data analysis, is no longer a futuristic ideal, but … Read more